» Articles » PMID: 24059681

Thermal Injury Lowers the Threshold for Radiation-induced Neuroinflammation and Cognitive Dysfunction

Overview
Journal Radiat Res
Specialties Genetics
Radiology
Date 2013 Sep 25
PMID 24059681
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The consequences of radiation exposure alone are relatively well understood, but in the wake of events such as the World War II nuclear detonations and accidents such as Chernobyl, other critical factors have emerged that can substantially affect patient outcome. For example, ~70% of radiation victims from Hiroshima and Nagasaki received some sort of additional traumatic injury, the most common being thermal burn. Animal data has shown that the addition of thermal insult to radiation results in increased morbidity and mortality. To explore possible synergism between thermal injury and radiation on brain, C57BL/6J female mice were exposed to either 0 or 5 Gy whole-body gamma irradiation. Irradiation was immediately followed by a 10% total-body surface area full thickness thermal burn. Mice were sacrificed 6 h, 1 week or 6 month post-injury and brains and plasma were harvested for histology, mRNA analysis and cytokine ELISA. Plasma analysis revealed that combined injury synergistically upregulates IL-6 at acute time points. Additionally, at 6 h, combined injury resulted in a greater upregulation of the vascular marker, ICAM-1 and TNF-α mRNA. Enhanced activation of glial cells was also observed by CD68 and Iba1 immunohistochemistry at all time points. Additionally, doublecortin staining at 6 months showed reduced neurogenesis in all injury conditions. Finally, using a novel object recognition test, we observed that only mice with combined injury had significant learning and memory deficits. These results demonstrate that thermal injury lowers the threshold for radiation-induced neuroinflammation and long-term cognitive dysfunction.

Citing Articles

"Monitoring inflammatory, immune system mediators, and mitochondrial changes related to brain metabolism during space flight".

Tocci D, Ducai T, Stoute C, Hopkins G, Sabbir M, Beheshti A Front Immunol. 2024; 15():1422864.

PMID: 39411717 PMC: 11473291. DOI: 10.3389/fimmu.2024.1422864.


Researches on cognitive sequelae of burn injury: Current status and advances.

Xie C, Hu J, Cheng Y, Yao Z Front Neurosci. 2022; 16:1026152.

PMID: 36408414 PMC: 9672468. DOI: 10.3389/fnins.2022.1026152.


Short and long-term evaluation of the impact of proton minibeam radiation therapy on motor, emotional and cognitive functions.

Lamirault C, Doyere V, Juchaux M, Pouzoulet F, Labiod D, Dendale R Sci Rep. 2020; 10(1):13511.

PMID: 32782370 PMC: 7419511. DOI: 10.1038/s41598-020-70371-w.


Neurogenic Effects of Low-Dose Whole-Body HZE (Fe) Ion and Gamma Irradiation.

Sweet T, Hurley S, Wu M, Olschowka J, Williams J, OBanion M Radiat Res. 2016; 186(6):614-623.

PMID: 27905869 PMC: 5240657. DOI: 10.1667/RR14530.1.

References
1.
Norden D, Godbout J . Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol. 2012; 39(1):19-34. PMC: 3553257. DOI: 10.1111/j.1365-2990.2012.01306.x. View

2.
Cherry J, Liu B, Frost J, Lemere C, Williams J, Olschowka J . Galactic cosmic radiation leads to cognitive impairment and increased aβ plaque accumulation in a mouse model of Alzheimer's disease. PLoS One. 2013; 7(12):e53275. PMC: 3534034. DOI: 10.1371/journal.pone.0053275. View

3.
Herber D, Mercer M, Roth L, Symmonds K, Maloney J, Wilson N . Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J Neuroimmune Pharmacol. 2007; 2(2):222-31. DOI: 10.1007/s11481-007-9069-z. View

4.
Palmer J, Deburghgraeve C, Bird M, Hauer-Jensen M, Kovacs E . Development of a combined radiation and burn injury model. J Burn Care Res. 2011; 32(2):317-23. PMC: 3062624. DOI: 10.1097/BCR.0b013e31820aafa9. View

5.
Matousek S, Ghosh S, Shaftel S, Kyrkanides S, Olschowka J, OBanion M . Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration. J Neuroimmune Pharmacol. 2011; 7(1):156-64. PMC: 3302720. DOI: 10.1007/s11481-011-9331-2. View